Trials / Sponsors / Context Therapeutics Inc.
Context Therapeutics Inc.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | CT-95 in Advanced Cancers Associated With Mesothelin Expression Mesothelin-Expressing Tumors, Epithelial Ovarian Cancer, Malignant Pleural Mesothelioma, Advanced | Phase 1 | 2025-03-31 |
| Recruiting | A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors Platinum-resistant Ovarian Cancer, Testicular Cancer, Endometrial Cancer | Phase 1 | 2024-07-10 |
| Withdrawn | A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advance Breast Cancer | Phase 1 / Phase 2 | 2023-06-01 |
| Terminated | Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2022-12-02 |